Publications

<

Year: 2025

Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece

Feb 17, 2025

Published on: Value in Health Regional Issues
Authors: Charalampos Tzanetakos, Marina Psarra, Ilias Kotsis, George Gourzoulidis,

Abstract Objectives: This study aimed to evaluate the cost-effectiveness of upadacitinib in patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response, lost response, or were intolerant to either conventional therapy...

Read More

Patient-reported outcomes in a Greek cross-sectional survey of inflammatory bowel disease patients treated with biologic therapy

Jan 25, 2025

Published on: Journal of Crohn's and Colitis
Authors: Charalampos Tzanetakos, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Charalampos Tzanetakos,

Abstract: Background Patient reported-outcomes [PROs] are a major therapeutic goal in inflammatory bowel disease [IBD]. The study objective was to investigate the burden of IBD and unmet medical need in patients who receive biologic therapy in Greece. Methods Between...

Read More

Archive per Year